Alnylam Pharmaceuticals reported $142.27M in Trade Debtors for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Trade Debtors Change
Acadia Pharmaceuticals ACAD:US $ 68.89M 5.41M
Agios Pharmaceuticals AGIO:US $ 4.3M 1.6M
Alnylam Pharmaceuticals ALNY:US $ 142.27M 14.26M
Amgen AMGN:US $ 5327M 250M
Arrowhead Research ARWR:US $ 0.24M 1.08M
Avrobio Inc AVRO:US 2.96M 116K
Biocryst Pharmaceuticals BCRX:US $ 41.49M 5.08M
Biomarin Pharmaceutical BMRN:US $ 466.51M 36.36M
Intercept Pharmaceuticals ICPT:US $ 27.52M 18.63M
IONIS PHARMACEUT IONS:US $ 6.75M 19.37M
Mirati Therapeutics MRTX:US $ 1.53M 0.28M
Moderna Inc MRNA:US 2.84B 520M
Neurocrine Biosciences NBIX:US $ 279M 15.5M
Novartis NVS:US $ 8910M 232M
Ptc Therapeutics PTCT:US $ 135.94M 5.34M
Regeneron Pharmaceuticals REGN:US $ 5161.4M 322.4M
Sangamo Biosciences SGMO:US $ 6.29M 1M
Sarepta Therapeutics SRPT:US $ 230.28M 33.07M
Takeda 4502:JP Y 794092M 69715M
Ultragenyx Pharmaceutical RARE:US $ 37.21M 8.84M
Vertex Pharmaceuticals VRTX:US $ 1332.9M 40.1M
Xencor XNCR:US $ 54.28M 38.92M
YTE INCY:US $ 682.97M 120.62M